Clinical Trials
73 trialsDAPPER
Mayo Clinic
TRAP
Royal Marsden NHS Foundation Trust
STEREOBED
Jules Bordet Institute
PROMPT
British Columbia Cancer Agency
ORION
Center Eugene Marquis
MRI-guided Locoregional SBRT Prostate Program
Clinica Universidad de Navarra, Universidad de Navarra
AQuOS-II
Sunnybrook Health Sciences Centre
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
M.D. Anderson Cancer Center
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
Mayo Clinic
SBRT Boost for Unfavorable Prostate Cancer'
MemorialCare Health System
PLATON
Canadian Cancer Trials Group
PROSTERA
Clinique Sainte Clotilde
GARUDA
Jonsson Comprehensive Cancer Center
Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer
Jonsson Comprehensive Cancer Center
METRO
Umeå University
Focal Radiotherapy for Previously Treated Prostate Cancer Patients
Royal North Shore Hospital
SBRTRC
IRCCS San Raffaele
HIMARS
Institut Cancerologie de l'Ouest
DE-CART
Fox Chase Cancer Center
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer
Hoag Memorial Hospital Presbyterian
Stereotactic Body Radiation Therapy With Boost Using Urethral-Sparing Intensity-Modulated Radiation Therapy Planning in Treating Patients With Prostate Cancer
University of Wisconsin, Madison
Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)
NYU Langone Health
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
MemorialCare Health System
HYDRA
Jonsson Comprehensive Cancer Center
Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate
Boston Medical Center
Single Fractions SBRT for Prostate Cancer
McGill University Health Centre/Research Institute of the McGill University Health Centre
PLUTO-MPC
Sunnybrook Health Sciences Centre
Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer
Icahn School of Medicine at Mount Sinai
A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer
Centre Hospitalier Universitaire Vaudois
STEREO-RE-PRO
UNICANCER
Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins
University Hospital Ostrava
Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial
Dana-Farber Cancer Institute
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer
Wake Forest University Health Sciences
OligoRARE
European Organisation for Research and Treatment of Cancer - EORTC
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
Beth Israel Deaconess Medical Center
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney Cancer
University of Chicago
Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery
Jonsson Comprehensive Cancer Center
Adaptive MR-guided SBRT for Localized Prostate Cancer
University of Zurich
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer
Case Comprehensive Cancer Center
Hypofractionated SBRT For Prostate Cancer
University of Pittsburgh
Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer
Sunnybrook Health Sciences Centre
HypoF-SBRT
University Hospital Freiburg
Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery
Albert Einstein College of Medicine
STEREO-RML
Centre Georges Francois Leclerc
MEDCARE
Universitaire Ziekenhuizen KU Leuven
SAFO
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry
Accuray Incorporated
CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
Accuray Incorporated
Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)
University of Alabama at Birmingham
Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery
University of Southern California